Modifications of etoposide induced toxicity by 2-deoxy-D-glucose in murine tumors

Seema Gupta, Rohit Mathur, B. S. Dwarakanath

Research output: Contribution to journalArticle

2 Citations (Scopus)

Abstract

Earlier studies have shown that 2-deoxy-D-glucose (2-DG), a glucose analogue and inhibitor of glycolytic ATP production, significantly enhances the cytotoxic effects of certain anticancer agents like topoisomerase inhibitors (etoposide and camptothecin) and a radiomimetic drug (bleomycin) in established human tumor cell lines. Therefore, combinations of 2-DG and DNA damage causing cytotoxic agents could be very useful in selectively destroying tumors, while sparing the normal tissues. The purpose of the present studies was to investigate the therapeutic effects of etoposide and 2-DG in Dalton's lymphoma and Ehrlich ascites tumor cells (EAT) in vivo (grown as solid tumor as well as in the ascites form in mice). Cell growth, cell cycle perturbations (flow cytometry), cytogenetic damage (micronuclei assay) and apoptosis (DNA content, light-scatter, morphological changes) were studied as parameters of cellular response, while delay in tumor growth and cure rate (tumor free survival) were evaluated as parameters of systemic response. Intravenous administration of etoposide (30 mg/Kg b. wt.) delayed the growth of both the tumors but a cure rate of ∼11% was observed only in subcutaneous EAT bearing mice. When etoposide was combined with 2-DG (2 g/Kg b. wt.; i.v; 4 h after etoposide injection), these effects were further enhanced in subcutaneous EAT bearing mice resulting in a cure rate of ∼22% but not in lymphoma bearing mice. Analysis of cells obtained from ascitic fluid as well as solid tumors during follow up clearly showed that etoposide induced cell death was mainly due to apoptosis in EAT as well as in lymphoma, which was enhanced further by 2-DG in EAT bearing mice. These results indicate that the combined treatment of etoposide and 2-DG can improve local control of tumors, thereby enhancing the treatment efficacy. Further studies are required to understand the mechanisms of chemosensitization by 2- DG both in vitro and in vivo.

Original languageEnglish (US)
Pages (from-to)31-44
Number of pages14
JournalBiomedicine
Volume24
Issue number1-2
StatePublished - 2004
Externally publishedYes

Fingerprint

Deoxyglucose
Etoposide
Ehrlich Tumor Carcinoma
Toxicity
Tumors
Bearings (structural)
Neoplasms
Lymphoma
Growth
Topoisomerase Inhibitors
Apoptosis
Camptothecin
Micronucleus Tests
Cells
Ascitic Fluid
Cytotoxins
Therapeutic Uses
Tumor Cell Line
Ascites
Cytogenetics

ASJC Scopus subject areas

  • Biochemistry, Genetics and Molecular Biology(all)

Cite this

Gupta, S., Mathur, R., & Dwarakanath, B. S. (2004). Modifications of etoposide induced toxicity by 2-deoxy-D-glucose in murine tumors. Biomedicine, 24(1-2), 31-44.

Modifications of etoposide induced toxicity by 2-deoxy-D-glucose in murine tumors. / Gupta, Seema; Mathur, Rohit; Dwarakanath, B. S.

In: Biomedicine, Vol. 24, No. 1-2, 2004, p. 31-44.

Research output: Contribution to journalArticle

Gupta, S, Mathur, R & Dwarakanath, BS 2004, 'Modifications of etoposide induced toxicity by 2-deoxy-D-glucose in murine tumors', Biomedicine, vol. 24, no. 1-2, pp. 31-44.
Gupta, Seema ; Mathur, Rohit ; Dwarakanath, B. S. / Modifications of etoposide induced toxicity by 2-deoxy-D-glucose in murine tumors. In: Biomedicine. 2004 ; Vol. 24, No. 1-2. pp. 31-44.
@article{5b0bb5a9f6e24a61a8e351d04d7544f7,
title = "Modifications of etoposide induced toxicity by 2-deoxy-D-glucose in murine tumors",
abstract = "Earlier studies have shown that 2-deoxy-D-glucose (2-DG), a glucose analogue and inhibitor of glycolytic ATP production, significantly enhances the cytotoxic effects of certain anticancer agents like topoisomerase inhibitors (etoposide and camptothecin) and a radiomimetic drug (bleomycin) in established human tumor cell lines. Therefore, combinations of 2-DG and DNA damage causing cytotoxic agents could be very useful in selectively destroying tumors, while sparing the normal tissues. The purpose of the present studies was to investigate the therapeutic effects of etoposide and 2-DG in Dalton's lymphoma and Ehrlich ascites tumor cells (EAT) in vivo (grown as solid tumor as well as in the ascites form in mice). Cell growth, cell cycle perturbations (flow cytometry), cytogenetic damage (micronuclei assay) and apoptosis (DNA content, light-scatter, morphological changes) were studied as parameters of cellular response, while delay in tumor growth and cure rate (tumor free survival) were evaluated as parameters of systemic response. Intravenous administration of etoposide (30 mg/Kg b. wt.) delayed the growth of both the tumors but a cure rate of ∼11{\%} was observed only in subcutaneous EAT bearing mice. When etoposide was combined with 2-DG (2 g/Kg b. wt.; i.v; 4 h after etoposide injection), these effects were further enhanced in subcutaneous EAT bearing mice resulting in a cure rate of ∼22{\%} but not in lymphoma bearing mice. Analysis of cells obtained from ascitic fluid as well as solid tumors during follow up clearly showed that etoposide induced cell death was mainly due to apoptosis in EAT as well as in lymphoma, which was enhanced further by 2-DG in EAT bearing mice. These results indicate that the combined treatment of etoposide and 2-DG can improve local control of tumors, thereby enhancing the treatment efficacy. Further studies are required to understand the mechanisms of chemosensitization by 2- DG both in vitro and in vivo.",
author = "Seema Gupta and Rohit Mathur and Dwarakanath, {B. S.}",
year = "2004",
language = "English (US)",
volume = "24",
pages = "31--44",
journal = "Biomedicine",
issn = "0970-2067",
publisher = "Indian Association of Biomedical Scientists",
number = "1-2",

}

TY - JOUR

T1 - Modifications of etoposide induced toxicity by 2-deoxy-D-glucose in murine tumors

AU - Gupta, Seema

AU - Mathur, Rohit

AU - Dwarakanath, B. S.

PY - 2004

Y1 - 2004

N2 - Earlier studies have shown that 2-deoxy-D-glucose (2-DG), a glucose analogue and inhibitor of glycolytic ATP production, significantly enhances the cytotoxic effects of certain anticancer agents like topoisomerase inhibitors (etoposide and camptothecin) and a radiomimetic drug (bleomycin) in established human tumor cell lines. Therefore, combinations of 2-DG and DNA damage causing cytotoxic agents could be very useful in selectively destroying tumors, while sparing the normal tissues. The purpose of the present studies was to investigate the therapeutic effects of etoposide and 2-DG in Dalton's lymphoma and Ehrlich ascites tumor cells (EAT) in vivo (grown as solid tumor as well as in the ascites form in mice). Cell growth, cell cycle perturbations (flow cytometry), cytogenetic damage (micronuclei assay) and apoptosis (DNA content, light-scatter, morphological changes) were studied as parameters of cellular response, while delay in tumor growth and cure rate (tumor free survival) were evaluated as parameters of systemic response. Intravenous administration of etoposide (30 mg/Kg b. wt.) delayed the growth of both the tumors but a cure rate of ∼11% was observed only in subcutaneous EAT bearing mice. When etoposide was combined with 2-DG (2 g/Kg b. wt.; i.v; 4 h after etoposide injection), these effects were further enhanced in subcutaneous EAT bearing mice resulting in a cure rate of ∼22% but not in lymphoma bearing mice. Analysis of cells obtained from ascitic fluid as well as solid tumors during follow up clearly showed that etoposide induced cell death was mainly due to apoptosis in EAT as well as in lymphoma, which was enhanced further by 2-DG in EAT bearing mice. These results indicate that the combined treatment of etoposide and 2-DG can improve local control of tumors, thereby enhancing the treatment efficacy. Further studies are required to understand the mechanisms of chemosensitization by 2- DG both in vitro and in vivo.

AB - Earlier studies have shown that 2-deoxy-D-glucose (2-DG), a glucose analogue and inhibitor of glycolytic ATP production, significantly enhances the cytotoxic effects of certain anticancer agents like topoisomerase inhibitors (etoposide and camptothecin) and a radiomimetic drug (bleomycin) in established human tumor cell lines. Therefore, combinations of 2-DG and DNA damage causing cytotoxic agents could be very useful in selectively destroying tumors, while sparing the normal tissues. The purpose of the present studies was to investigate the therapeutic effects of etoposide and 2-DG in Dalton's lymphoma and Ehrlich ascites tumor cells (EAT) in vivo (grown as solid tumor as well as in the ascites form in mice). Cell growth, cell cycle perturbations (flow cytometry), cytogenetic damage (micronuclei assay) and apoptosis (DNA content, light-scatter, morphological changes) were studied as parameters of cellular response, while delay in tumor growth and cure rate (tumor free survival) were evaluated as parameters of systemic response. Intravenous administration of etoposide (30 mg/Kg b. wt.) delayed the growth of both the tumors but a cure rate of ∼11% was observed only in subcutaneous EAT bearing mice. When etoposide was combined with 2-DG (2 g/Kg b. wt.; i.v; 4 h after etoposide injection), these effects were further enhanced in subcutaneous EAT bearing mice resulting in a cure rate of ∼22% but not in lymphoma bearing mice. Analysis of cells obtained from ascitic fluid as well as solid tumors during follow up clearly showed that etoposide induced cell death was mainly due to apoptosis in EAT as well as in lymphoma, which was enhanced further by 2-DG in EAT bearing mice. These results indicate that the combined treatment of etoposide and 2-DG can improve local control of tumors, thereby enhancing the treatment efficacy. Further studies are required to understand the mechanisms of chemosensitization by 2- DG both in vitro and in vivo.

UR - http://www.scopus.com/inward/record.url?scp=8744242407&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=8744242407&partnerID=8YFLogxK

M3 - Article

VL - 24

SP - 31

EP - 44

JO - Biomedicine

JF - Biomedicine

SN - 0970-2067

IS - 1-2

ER -